Xenex

Xenex develops UV germ-zapping robots designed to combat harmful bacteria, viruses, and spores in healthcare environments, significantly reducing the risk of hospital-acquired infections (HAIs). The company’s flagship robot, LightStrike+, is the first FDA-approved device of its kind. Leveraging high-intensity, pulsed xenon ultraviolet light, LightStrike+ can neutralize pathogens in just five minutes. The robot activates automatically when it senses human absence through the lack of motion and heat signatures. Its 360-degree light projection disinfects spaces efficiently, while in larger or more complex environments like pharmaceutical labs, the robot autonomously moves to ensure thorough cleaning. Xenex’s cloud-based reporting system tracks key metrics such as operator activity and locations disinfected. The company also offers a handheld UV device tailored for compact spaces.

With Xenex’s hybrid hardware-as-a-service (HaaS) model, customers purchase the robots upfront and pay a subscription fee for comprehensive, end-to-end services. In 2020, LightStrike+ cost $125,000, and the subscription price translates to about $4 per cleaned room per day. Subscriptions include 24/7 customer care, training and educational support, predictive maintenance, remote diagnostics, automatic software updates, a self-service portal so customers can monitor their program in real-time, and monthly performance and compliance reports.